Clinical Trials Browser

Phase 2 × Graft vs Host Disease × Pentostatin × Clear all

NCT00096161 2020-01-31

Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT00923845 2017-09-29

Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

Phase 2 Completed

25 enrolled 23 charts

Genitourinary

Carcinoma, Renal Cell, Graft vs Host Disease, Kidney Neoplasms

NCT00144430 2009-02-03

Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children

Phase 2 Completed

60 enrolled

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Leukemia